{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:40:54Z","timestamp":1770478854619,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T00:00:00Z","timestamp":1132531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T00:00:00Z","timestamp":1132531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1038\/sj.bmt.1705226","type":"journal-article","created":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T11:48:23Z","timestamp":1132573703000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome"],"prefix":"10.1038","volume":"37","author":[{"given":"N","family":"Kr\u00f6ger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"van Biezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-Y","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,21]]},"reference":[{"key":"BF1705226_CR1","first-page":"47","volume":"19","author":"EG Levine","year":"1992","unstructured":"Levine EG, Bloomfield CD . Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 1992; 19: 47\u201384.","journal-title":"Semin Oncol"},{"key":"BF1705226_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","volume":"106","author":"DW Milligan","year":"1999","unstructured":"Milligan DW, Ruiz De Elvira MC, Kolb HJ, Goldstone AH, Meloni G, Rohatiner AZ et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol 1999; 106: 1020\u20131026.","journal-title":"Br J Haematol"},{"key":"BF1705226_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","volume":"102","author":"SM Smith","year":"2003","unstructured":"Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43\u201352.","journal-title":"Blood"},{"key":"BF1705226_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1023\/A:1008375016038","volume":"11","author":"C Linassier","year":"2000","unstructured":"Linassier C, Barin C, Calais G, Letortorec S, Bremond JL, Delain M et al. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 2000; 11: 1289\u20131294.","journal-title":"Ann Oncol"},{"key":"BF1705226_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s004320050156","volume":"124","author":"C Kollmannsberger","year":"1998","unstructured":"Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C . Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 1998; 124: 207\u2013214.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF1705226_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","volume":"1400","author":"CA Felix","year":"1998","unstructured":"Felix CA . Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1998; 1400: 233\u2013255.","journal-title":"Biochim Biophys Acta"},{"key":"BF1705226_CR7","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1200\/JCO.1998.16.5.1897","volume":"16","author":"J Pedersen-Bjergaard","year":"1998","unstructured":"Pedersen-Bjergaard J, Andersen MK, Johansson B . Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Clin Oncol 1998; 16: 1897\u20131898.","journal-title":"J Clin Oncol"},{"key":"BF1705226_CR8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V76.6.1083.1083","volume":"76","author":"J Pedersen-Bjergaard","year":"1990","unstructured":"Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K . Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083\u20131091.","journal-title":"Blood"},{"key":"BF1705226_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1200\/JCO.1986.4.4.589","volume":"4","author":"VJ Picozzi Jr","year":"1986","unstructured":"Picozzi Jr VJ, Swanson GF, Morgan R, Hecht F, Greenberg PL . 13-cis retinoic acid treatment for myelodysplastic syndromes. J Clin Oncol 1986; 4: 589\u2013595.","journal-title":"J Clin Oncol"},{"key":"BF1705226_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0889-8588(18)30253-3","volume":"7","author":"KK Ballen","year":"1993","unstructured":"Ballen KK, Antin JH . Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes. Hematol Oncol Clin North Am 1993; 7: 477\u2013493.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF1705226_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0889-8588(18)30259-4","volume":"7","author":"HM Kantarjian","year":"1993","unstructured":"Kantarjian HM, Estey EH, Keating MJ . Treatment of therapy-related leukemia and myelodysplastic syndrome. Hematol Oncol Clin North Am 1993; 7: 81\u2013107.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF1705226_CR12","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.1993.11.12.2370","volume":"11","author":"B Quesnel","year":"1993","unstructured":"Quesnel B, Kantarjian H, Bjergaard JP, Brault P, Estey E, Lai JL et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993; 11: 2370\u20132379.","journal-title":"J Clin Oncol"},{"key":"BF1705226_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","volume":"18","author":"I Yakoub-Agha","year":"2000","unstructured":"Yakoub-Agha I, de La SP, Ribaud P, Sutton L, Wattel E, Kuentz M et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients \u2013 report of the French society of bone marrow transplantation. J Clin Oncol 2000; 18: 963\u2013971.","journal-title":"J Clin Oncol"},{"key":"BF1705226_CR14","first-page":"3853","volume":"90","author":"T de Witte","year":"1997","unstructured":"de Witte T, van Biezen A, Hermans J, Labopin M, Runde V, Or R et al. Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Blood 1997; 90: 3853\u20133857.","journal-title":"Blood"},{"key":"BF1705226_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","volume":"110","author":"T de Witte","year":"2000","unstructured":"de Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N et al. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000; 110: 620\u2013630.","journal-title":"Br J Haematol"},{"key":"BF1705226_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bmt.1700971","volume":"20","author":"KK Ballen","year":"1997","unstructured":"Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ et al. Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia. Bone Marrow Transplant 1997; 20: 737\u2013743.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705226_CR17","first-page":"88a","volume":"100","author":"AH Goldstone","year":"2002","unstructured":"Goldstone AH, Burnett AK, Avivi I . Secondary acute myeloid leukemia has a worse outcome in MRC trials. Blood 2002; 100: 88a (abstract 322).","journal-title":"Blood"},{"key":"BF1705226_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.leu.2403187","volume":"18","author":"C Schoch","year":"2004","unstructured":"Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T . Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004; 18: 120\u2013125.","journal-title":"Leukemia"},{"key":"BF1705226_CR19","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1200\/JCO.2004.99.301","volume":"22","author":"W Kern","year":"2004","unstructured":"Kern W, Haferlach T, Schnittger S, Hiddemann W, Schoch C . Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 2004; 22: 2510\u20132511.","journal-title":"J Clin Oncol"},{"key":"BF1705226_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.leu.2401387","volume":"13","author":"E Wattel","year":"1999","unstructured":"Wattel E, Solary E, Leleu X, Dreyfus F, Brion A, Jouet JP et al. A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Francais des Myelodysplasies. Group Ouest-Est d'etude des Leucemies aigues myeloides. Leukemia 1999; 13: 524\u2013529.","journal-title":"Leukemia"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705226","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:13:52Z","timestamp":1648080832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,21]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["BF1705226"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705226","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,21]]},"assertion":[{"value":"10 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}